Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice.Molecular Psychiatry · 2026-07-06Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons.Unknown journal · 2026-03-26Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronsResearch Square · 2026-01-06The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.Unknown journal · 2025-12-25Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativitybioRxiv · 2025-11-06Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigmUniversität Zürich, ZORA · 2025-11-04Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.Psychopharmacology · 2025-07-31Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.Unknown journal · 2025-07-30Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substancesSwiss Medical Weekly · 2025-06-30Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics.Unknown journal · 2025-04-22Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländernedoc Publication server (Humboldt University of Berlin) · 2025-02-11Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.Unknown journal · 2025-01-31The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-21Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativityResearch Square · 2024-09-25Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.Unknown journal · 2024-09-11Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-04-30Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of ConsciousnessPsyArXiv · 2023-06-03ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study DesignNeuromodulation Technology at the Neural Interface · 2023-05-31The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.Unknown journal · 2023-05-28[Attitudes of Mental Health Experts Towards Psilocybin].Fortschritte der Neurologie · Psychiatrie · 2022-06-19Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).PLoS ONE · 2022-03-15Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.Psychopharmacology · 2022-01-24Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.Unknown journal · 2021-07-22Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-01Dose-response relationships of psilocybin-induced subjective experiences in humans.Unknown journal · 2021-03-03How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humansbioRxiv · 2020-06-10Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.Clinical pharmacokinetics · 2017-09-30[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Unknown journal · 2017-06-30Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Journal of Psychopharmacology · 2016-11-30Alterations of consciousness and mystical-type experiences after acute LSD in humans.Psychopharmacology · 2016-10-06The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?Journal of psychopharmacology (Oxford, England) · 2015-02-28Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.Journal of Neuroscience · 2013-05-31Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual HallucinationsOpen MIND · 2012-12-31The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2012-07-26Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological Psychiatry · 2012-05-09Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.Unknown journal · 2011-10-25Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.Unknown journal · 2002-12-31Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.Unknown journal · 2002-02-28177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophreniaBiological Psychiatry · 2000-03-31